Ann: Three Complete Responses in Azer-Cel Phase 1b Trial, page-337

The clinical trial's team is excellent at IMU. People can look at the history all the way from Bcell products. For instance, bringing in patients and hospitals across the geographies alike.

Top management has also walked along the similar lines as the clinical trials team, barring the last 8 cents CR ( Which in my books is a huge miss).

Now after latest Azercell results and a few more product lines data due in few months, all eyes wud be on monil to perform. If there is another low ball CR done in next few months that shall / should be considered a huge failure on monil's front........ I can't think of another name in the team that sticks out as much as monil, interms of needing to perform.

Go Imu....... Keep up the great work.
DYOR
SS